GeriUK-US Pharmaceutical Deal Could Lead to 229,000 Excess Deaths, Study Warns

Sağlık

Al Jazeera02.07.2026Sağlık4 dk okuma

UK-US Pharmaceutical Deal Could Lead to 229,000 Excess Deaths, Study Warns

Research in BMJ highlights potential consequences of diverting NHS funds to US medicines

NHS UK-US Trade Deal Pharmaceutical Spending

Hızlı Bakış

A UK-US pharmaceutical trade deal may cause 229,000 excess deaths in the UK by 2036 due to diverted NHS funding, according to BMJ research, as billions are allocated to US medicines with no additional NHS funding

Yapay zekâ özeti

Yazı boyutu

Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS)... (full article text preserved with paragraph breaks)

İlgili Konular

NHS

KonularUK-US Trade Deal Pharmaceutical Spending Healthcare Funding

Bu haber ilk olarak şurada yayınlandı: Al Jazeera.

İlgili Haberler

Bu konuda daha fazlaNHS

Gelişiyor·1 saat önce

Nearly 1.6 Million Dozen Eggs Recalled Over Salmonella Fears Amid Rising Foodborne Illness Outbreaks

Nearly 1.6 million dozen eggs from Midwest Poultry Services are recalled across five US states due to potential Salmonella contamination. This recall coincides with a major cyclosporiasis outbreak linked to contaminated lettuce, affecting thousands nationwide, raising concerns about foodborne illnesses.

The Independent World

2 dk okuma

Gelişiyor·4 saat önce

NHS Pays Out £190m in Five Years for Cancer Misdiagnosis Claims

Darren Rosheski settled a lawsuit against the NHS after his partner, Helen Dutton, died from advanced cancer following an initial misdiagnosis. New figures reveal the NHS in England paid nearly £190m over five years for 870 cancer misdiagnosis claims, with average settlement costs rising 20%.

Guardian International

5 dk okuma

SON DAKİKA·9 saat önce

US Regulators to Decide on Peptide Availability Amid Safety Concerns and Popularity Boom

US Food and Drug Administration's advisory committee will meet to decide if seven peptides, marketed for various wellness treatments, can be compounded by licensed pharmacies. The review comes amid soaring popularity, safety concerns from the FDA, and controversy over committee members' ties to peptide businesses.

Al Jazeera

4 dk okuma

Gelişiyor·9 saat önce

WHO Reports Rapid Spread of New Ebola Strain in Congo, Uganda

The World Health Organization published new data showing the current Ebola outbreak in Congo, involving a new Bundibugyo strain, is spreading at the fastest rate ever recorded, with over 1,000 deaths in Congo and Uganda. Lack of vaccines, medicine, and funding, alongside attacks on health workers, are compounding the crisis.

Deutsche Welle

2 dk okuma

Sağlık·9 saat önce

Strategies for Reducing Ultra-Processed Foods in Family Diets

An individual shares their family's five-year journey and eight practical strategies for reducing ultra-processed foods (UPF) in their diet, drawing on expert advice from Kary Rappaport, Julia Wolfson, and Penny Stankiewicz, emphasizing plant-based eating, cooking skills, and consistency.

Guardian International

8 dk okuma

Sağlık·11 saat önce

Three-year-old girl bitten by rattlesnake while retrieving Amazon package

A three-year-old girl, Addy, was bitten by a Southern Pacific rattlesnake hiding under an Amazon package in Santa Clarita, California, on July 13. She received multiple doses of anti-venom in a pediatric ICU and is now recovering well, despite the increase in rattlesnake bites in California this year.

Guardian International

1 dk okuma

Bu konuda daha fazlaNHS